ZNTLZENTALIS PHARMACEUTICALS INC
CUSIP 98943L107 · common stock
2 tracked investors held ZENTALIS PHARMACEUTICALS INC (ZNTL) at the end of Q3 2026, worth $13.1M in total. The largest holder was Adar1 Capital Management, with 0.4% of its portfolio.
Holders · Q3 2026
2
New holders
0
Value held
$13.1M
Quarter-end price (est.)
$2.77
Investors holding ZNTL · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.44% | 3,762,532 | $10.4M | ADD+476.4% |
| PRIMECAP Management PRIMECAP Management Co | 0.00% | 957,420 | $2.7M | HOLD |